Gotto, G. ., Drachenberg, D. E. ., Chin, J. ., Casey, R. ., Fradet, V. ., Sabbagh, R. ., Shayegan, B. ., Rendon, R. A. ., Danielson, B. ., Camacho, F. ., Zardan, A. ., Plante, R. ., Hew, H. ., Chan, K., & Feifer, A. . (2020). Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. Canadian Urological Association Journal, 14(12), E616–20. https://doi.org/10.5489/cuaj.6388